Anonymous
Guest
Anonymous
Guest
No more paper calls, no sp, no rts, and no deletes= NO REACH AND NO FREGUENCY!!
No more paper calls, no sp, no rts, and no deletes= NO REACH AND NO FREGUENCY!!
if you are not leaving samples just get the gatekeeper or nurse, MA to scribble a signature.
Let’s clarify things here folks.
No other legitimate pharmaceutical company requires their reps to obtain signatures on calls unless they have left Rx samples. This does not occur in the dedicated division of PDI with the exception of only a few contracts.
If you don’t believe me ask a PDI dedicated rep or the Merk or Glaxo or any other big pharma rep.
Do not let any district manager or PDI home office liar tell you differently.
Again, if you don’t believe me please ask other reps from real companies.
The reason PDI Select Access requires a signature for all calls is that is the agreement they made with the client to prove that their reps are making contact with the appropriate target. It is not an FDA or state requirement to obtain a signature for leaving literature or OTC products.
By working for PDI you have agreed to follow their policies.
I personally think it is unprofessional for a representative to ask for a signature for detail only or when leaving an OTC product.
PDI does not treat its Select Access representatives like professional pharmaceutical representatives and obviously don’t trust them.
Until PDI Select Access decides to actually treat the rep as professionals they will continue to flounder.
The quality of the managers and top leadership is getting worse every year as they become more desperate for business. They agree to too many conditions on contracts that are counterproductive and not realistic. i.e. (5 % shared practice and 5% refused to signs.)
SA keeps making the same mistakes year after year with providing the reps with bad target lists and then wonder why people don’t meet reach and frequency.
Don’t promise to do something you can’t deliver PDI! Don’t sell your company or the reps short by agreeing to meet unrealistic metrics in contracts. You have negotiated the last few SA contracts poorly. You gave the store away when you agreed to let Genentech cherry pick are most loyal Tamiflu prescribers. You have either no brains or no balls.
The bottom line is you have to pay the reps fairly and let your representatives to use professional judgment. When you do that you will get real production. You have not done this and this is why this division will ultimately fail.
How would you have handled the above scenario when you were with full time pharma, calling on three targets twice a month? Would you still try six times a month, go once a month, or not try at all? Just curious.I worked for PDI for five weeks in 2010. After 21 years in full time pharma, I was looking for the perfect 'part time' job. The signature thing was strictly enforced and there were days I didn't get any signatures; hence no pay! Many docs refused to sign because I had no samples. I also had little or no literature to leave behind. One example: I had three targets in one office and was expected to see each of them twice a month. I would have had to go back to that office (without samples) six times to get six signatures a month. I had nothing to offer...the product was not new, it had terrible formulary coverage, I had no rebates or discount cards, nothing! Even the MAs didnt' want to see me. I felt like my goal each day was not to SELL, but my goal was to GET SIGNATURES!!
When I was in full time pharma, I averaged about 60% signature calls FOR SAMPLES! The other 40% were unsigned calls but my company TRUSTED ME!! They knew I was out there working and selling!!!!!
It could have been the perfect part time job and unfortunately, PDI lost an excellent employee in me. Based on the turn over rate, they continue to lose excellent reps! When will they learn????
Let's be honest, if you actually work in the field you know all those things are important in moderation. PDI is not very realistic. The manager that previously posted has not carried a bag for PDI. Quit dictating!
Let’s clarify things here folks.
No other legitimate pharmaceutical company requires their reps to obtain signatures on calls unless they have left Rx samples. This does not occur in the dedicated division of PDI with the exception of only a few contracts.
If you don’t believe me ask a PDI dedicated rep or the Merk or Glaxo or any other big pharma rep.
Do not let any district manager or PDI home office liar tell you differently.
Again, if you don’t believe me please ask other reps from real companies.
The reason PDI Select Access requires a signature for all calls is that is the agreement they made with the client to prove that their reps are making contact with the appropriate target. It is not an FDA or state requirement to obtain a signature for leaving literature or OTC products.
By working for PDI you have agreed to follow their policies.
I personally think it is unprofessional for a representative to ask for a signature for detail only or when leaving an OTC product.
PDI does not treat its Select Access representatives like professional pharmaceutical representatives and obviously don’t trust them.
Until PDI Select Access decides to actually treat the rep as professionals they will continue to flounder.
The quality of the managers and top leadership is getting worse every year as they become more desperate for business. They agree to too many conditions on contracts that are counterproductive and not realistic. i.e. (5 % shared practice and 5% refused to signs.)
SA keeps making the same mistakes year after year with providing the reps with bad target lists and then wonder why people don’t meet reach and frequency.
Don’t promise to do something you can’t deliver PDI! Don’t sell your company or the reps short by agreeing to meet unrealistic metrics in contracts. You have negotiated the last few SA contracts poorly. You gave the store away when you agreed to let Genentech cherry pick are most loyal Tamiflu prescribers. You have either no brains or no balls.
The bottom line is you have to pay the reps fairly and let your representatives to use professional judgment. When you do that you will get real production. You have not done this and this is why this division will ultimately fail.
Let’s clarify things here folks.
No other legitimate pharmaceutical company requires their reps to obtain signatures on calls unless they have left Rx samples. This does not occur in the dedicated division of PDI with the exception of only a few contracts.
If you don’t believe me ask a PDI dedicated rep or the Merk or Glaxo or any other big pharma rep.
Do not let any district manager or PDI home office liar tell you differently.
Again, if you don’t believe me please ask other reps from real companies.
The reason PDI Select Access requires a signature for all calls is that is the agreement they made with the client to prove that their reps are making contact with the appropriate target. It is not an FDA or state requirement to obtain a signature for leaving literature or OTC products.
By working for PDI you have agreed to follow their policies.
I personally think it is unprofessional for a representative to ask for a signature for detail only or when leaving an OTC product.
PDI does not treat its Select Access representatives like professional pharmaceutical representatives and obviously don’t trust them.
Until PDI Select Access decides to actually treat the rep as professionals they will continue to flounder.
The quality of the managers and top leadership is getting worse every year as they become more desperate for business. They agree to too many conditions on contracts that are counterproductive and not realistic. i.e. (5 % shared practice and 5% refused to signs.)
SA keeps making the same mistakes year after year with providing the reps with bad target lists and then wonder why people don’t meet reach and frequency.
Don’t promise to do something you can’t deliver PDI! Don’t sell your company or the reps short by agreeing to meet unrealistic metrics in contracts. You have negotiated the last few SA contracts poorly. You gave the store away when you agreed to let Genentech cherry pick are most loyal Tamiflu prescribers. You have either no brains or no balls.
The bottom line is you have to pay the reps fairly and let your representatives to use professional judgment. When you do that you will get real production. You have not done this and this is why this division will ultimately fail.
How would you have handled the above scenario when you were with full time pharma, calling on three targets twice a month? Would you still try six times a month, go once a month, or not try at all? Just curious.
okay, what is so different about the T contract based on your response above.We had a lunch budget (could see 2-3 docs at lunch) money for coffee/donuts, we had SAMPLES!!!!, We had clinical studies, slim jims, dose cards..we had resources..we could go back weekly without feeling stupid..how can you not understand???!!!